|
End-of-day quote
Mexican S.E.
2026-08-25
|
5-day change | 1st Jan Change | ||
| 2,520.00 MXN | +1.82% |
|
+5.52% | +13.40% |
| 08-25 | Wall Street Wants Receipts |  |
| 08-25 | Lakefront Biotherapeutics, Gilead Secure Another Orphan Drug Designation for Skin Disorder Drug in US | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3.59% | -2.96% | -0.55% | +11.68% | +10.68% | +71.06% | +114.83% | +350.76% | +1,424.69% | 1,100B | |
| -1.15% | -0.41% | +2.51% | +15.22% | +30.47% | +51.34% | +62.41% | +54.97% | +127.71% | 658B | |
| -1.09% | +1.54% | +1.36% | +21.88% | +15.06% | +26.67% | +79.22% | +118.36% | +306.21% | 470B | |
| -1.47% | +2.05% | +3.72% | +10.10% | +12.22% | +41.71% | +42.09% | +1.70% | +53.27% | 372B | |
| -0.90% | +1.29% | +0.22% | +6.46% | +16.04% | +25.62% | +41.75% | +51.73% | +64.53% | 304B | |
| -1.94% | +1.53% | -5.07% | -12.36% | -11.28% | +3.05% | +13.24% | +42.59% | +146.90% | 264B | |
| -0.43% | +3.54% | +17.10% | +29.78% | +34.53% | +52.65% | +71.75% | +98.72% | +158.67% | 239B | |
| -0.93% | +2.90% | -4.88% | +5.52% | -6.24% | -16.98% | -52.28% | -6.71% | +95.73% | 213B | |
| -0.46% | +3.24% | +14.52% | +10.22% | +20.65% | +29.73% | +92.67% | +107.38% | +84.93% | 184B | |
| -0.95% | +3.85% | +15.32% | +9.27% | +13.65% | +12.57% | -22.21% | -40.43% | -18.61% | 163B | |
| -1.01% | +3.62% | +14.65% | +25.95% | +20.72% | +40.71% | +56.34% | +171.84% | +467.85% | 140B | |
| -0.52% | +2.30% | +8.83% | +13.64% | +25.27% | +43.34% | +8.84% | -0.04% | +14.99% | 139B | |
| -0.57% | +0.80% | +2.97% | +1.07% | -5.36% | -9.24% | -20.69% | -11.07% | +14.18% | 110B | |
| -0.31% | -0.86% | -3.14% | -1.32% | +4.11% | +29.26% | +35.89% | +2.77% | -7.88% | 104B | |
| +1.45% | +2.41% | +2.96% | -7.05% | -14.46% | +17.30% | +59.78% | +64.55% | +553.88% | 71.79B | |
| +0.81% | +1.58% | +1.58% | +15.81% | +21.20% | +33.12% | +31.04% | +59.89% | +30.54% | 58.27B | |
| -0.30% | +0.76% | +6.62% | +27.86% | +32.69% | +74.74% | -1.88% | +2.81% | -48.87% | 56.48B | |
| -0.58% | -11.23% | -13.02% | -5.95% | -21.96% | -29.84% | +14.17% | -1.94% | +183.98% | 45.53B | |
| +1.00% | +4.30% | +0.84% | +9.18% | -0.40% | +4.33% | +14.30% | - | - | 44.39B | |
| Average | -0.44% | +1.99% | +3.50% | +9.84% | +10.40% | +26.38% | +33.75% | +59.32% | +202.93% | 249.22B | |
| Weighted average by Cap. | -0.62% | +2.17% | +2.83% | +11.60% | +13.84% | +39.07% | +57.81% | +121.90% | +438.97% |
- Stock Market
- Stocks
- GILD Stock
- GILD * Stock
- Sector Gilead Sciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
